X-ray crystallographic structure-based design of selective thienopyrazole inhibitors for interleukin-2-inducible tyrosine kinase.
McLean, L.R., Zhang, Y., Zaidi, N., Bi, X., Wang, R., Dharanipragada, R., Jurcak, J.G., Gillespy, T.A., Zhao, Z., Musick, K.Y., Choi, Y.M., Barrague, M., Peppard, J., Smicker, M., Duguid, M., Parkar, A., Fordham, J., Kominos, D.(2012) Bioorg Med Chem Lett 22: 3296-3300
- PubMed: 22464456 
- DOI: 10.1016/j.bmcl.2012.03.016
- Primary Citation of Related Structures:  
3V5J, 3V5L, 3V8T, 3V8W, 3VF8, 3VF9 - PubMed Abstract: 
Beginning with a screening hit, unique thienopyrazole-indole inhibitors of Itk (interleukin-2-inducible tyrosine kinase) were designed, synthesized, and crystallized in the target kinase. Although initial compounds were highly active in Itk, they were not selective ...